Abstract
Cystinosis is an autosomal recessive lysosomal storage disease caused by mutations in CTNS. The most prevalent CTNS mutation, a 57-kb deletion, occurs in ~60% of patients in the United States and northern Europe and removes exons 1–9, most of exon 10, the CTNS promoter region, and all of an adjacent gene of unknown function called CARKL. CTNS codes for the lysosomal cystine transporter, whose absence leads to intracellular cystine accumulation, widespread cellular destruction, renal Fanconi syndrome in infancy, renal glomerular failure in later childhood, and other systemic complications. Because treatment with oral cysteamine can prevent or delay these complications significantly, early and accurate diagnosis is critical. This study describes the generation of fluorescence in situ hybridization (FISH) probes for the 57-kb deletion in CTNS, enabling cytogenetics laboratories to test for this common mutation. The probes would also be able to detect a less frequent 11.7-kb deletion. A blinded study was performed using multiplex PCR analysis as the gold standard to determine the presence or absence of the 57-kb deletion. The FISH probes, evaluated on 12 lymphoblastoid cell lines from singly deleted, doubly deleted, and nondeleted patients, made the correct diagnosis in every case. This appears to be the first FISH-based diagnostic method described for any lysosomal storage disorder. It can assist in the antenatal and perinatal diagnosis of cystinosis and promote earlier salutary therapy with cysteamine.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anikster Y, Lucero C, Touchman JW, Huizing M, McDowell G, Shotelersuk V, Green ED, Gahl WA (1999) Identification and detection of the common 65-kb deletion breakpoint in the nephropathic cystinosis gene (CTNS). Mol Genet Metab 66:111–116
Forestier L, Jean G, Attard M, Cherqui S, Lewis C, van’t Hoff W, Broyer M, Town M, Antignac C (1999) Molecular characterization of CTNS deletions in nephropathic cystinosis: development of a PCR-based detection assay. Am J Hum Genet 65:353–359
Gahl WA (2003) Early oral cysteamine therapy for nephropathic cystinosis. Eur J Pediatr 162:S38–S41
Gahl WA, Bashan N, Tietze F, Bernardini I, Schulman JD (1982) Lysosomal cystine transport is defective in cystinosis. Science 217:1263–1265
Gahl WA, Reed GF, Thoene JG, Schulman JD, Rizzo WB, Jonas AJ, Denman DW, Schlesselman JJ, Corden BJ, Schneider JA (1987) Cysteamine therapy for children with nephropathic cystinosis. N Engl J Med 316:971–977
Gahl WA, Kuehl EM, Iwata F, Lindblad A, Kaiser-Kupfer MI (2000) Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops. Mol Genet Metab 71:100–120
Gahl WA, Thoene J, Schneider JA (2001) Cystinosis: a disorder of lysosomal membrane transport. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Vogelstein B (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 5085–5108
Gahl WA, Thoene JG, Schneider JA (2002) Cystinosis. N Engl J Med 347:111–121
Gretz N, Manz F, Augustin R, Barrat TM, Bender-Gotze C, Brandis M, Bremer HJ et al (1983) Survival time in cystinosis: a collaborative study. Proc Eur Dial Transplant Assoc Eur Ren Assoc 19:582–589
Haddad B, Pabon-Pena CR, Young H, Sun WH (1998) Assignment of STAT1 to human chromosome 2q32 by FISH and radiation hybrids. Cytogenet Cell Genet 83:58–59
Kaiser-Kupfer MI, Fujikawa L, Kuwabara T, Gahl WA (1987) Removal of corneal crystals by topical cysteamine in nephropathic cystinosis. N Engl J Med 316:775–779
Kimonis VE, Troendle J, Yang ML, Rose SR, Markello TC, Gahl WA (1995) Effects of early cysteamine therapy on thyroid function and growth in nephropathic cystinosis. J Clin Endocrinol Metab 80:3257–3261
Kleta R, Anikster Y, Lucero C, Shotelersuk V, Huizing M, Bernardini I, Park M, Thoene J, Schneider J, Gahl WA (2001) CTNS mutations in African American patients with cystinosis. Mol Genet Metab 74:332–337
Kleta R, Bernardini I, Ueda M, Varade WS, Phornphutkul C, Krasnewich D, Gahl WA (2004) Long-term follow-up of well-treated nephropathic cystinosis patients. J Pediatr (in press)
Markello TC, Bernardini IM, Gahl WA (1993) Improved renal function in children with cystinosis treated with cysteamine. N Engl J Med 328:1157–1162
Mason S, Pepe G, Dall’Amico R, Tartaglia S, Casciani S, Greco M, Bencivenga P, Murer L, Rizzoni G, Tenconi R, Clementi M (2003) Mutational spectrum of the CTNS gene in Italy. Eur J Hum Genet 11:503–508
Milunsky JM, Cheney SM (1999) Prenatal diagnosis of spinal muscular atrophy by direct molecular analysis: efficacy and potential pitfalls. Genet Test 3:255–258
Pisoni RL, Thoene JG, Christensen HN (1985) Detection and characterization of carrier-mediated cationic amino acid transport in lysosomes of normal and cystinotic human fibroblasts. J Biol Chem 260:4791–4798
Shotelersuk V, Larson D, Anikster Y, McDowell G, Lemons R, Bernardini I, Guo J, Thoene J, Gahl WA (1998) CTNS mutations in an American-based population of cystinosis patients. Am J Hum Genet 63:1352–1362
Smith ML, Pellett OL, Cass MM, Kennaway NG, Buist NR, Buckmaster J, Golbus M, Spear GS, Schneider JA (1987) Prenatal diagnosis of cystinosis utilizing chorionic villus sampling. Prenat Diagn 7:23–26
Smolin LA, Clark KF, Schneider JA (1987) An improved method for heterozygote detection of cystinosis, using polymorphonuclear leukocytes. Am J Hum Genet 41:266–275
The Cystinosis Collaborative Research Group (1995) Linkage of the gene for cystinosis to markers on the short arm of chromosome 17. Nat Genet 10:246–248
Theodoropoulos DS, Krasnewich D, Kaiser-Kupfer MI, Gahl WA (1993) Classical nephropathic cystinosis as an adult disease. JAMA 270:2200–2204
Thoene JG, Oshima RG, Crawhall JC, Olson DL, Schneider JA (1976) Cystinosis. Intracellular cystine depletion by aminothiols in vitro and in vivo. J Clin Invest 58:180–189
Touchman JW, Anikster Y, Dietrich NL, Maduro VV, McDowell G, Shotelersuk V, Bouffard GG, Beckstrom-Sternberg SM, Gahl WA, Green ED (2000) The genomic region encompassing the nephropathic cystinosis gene (CTNS): complete sequencing of a 200-kb segment and discovery of a novel gene within the common cystinosis-causing deletion. Genome Res 10:165–173
Town M, Jean G, Cherqui S, Attard M, Forestier L, Whitmore SA, Callen DF, Gribouval O, Broyer M, Bates GP, van’t Hoff W, Antignac C (1998) A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nat Genet 18:319–324
Acknowledgements
This research was supported by grants from the Region Bretagne (A2CAL8), Rennes University Hospital (concours post-internat).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bendavid, C., Kleta, R., Long, R. et al. FISH diagnosis of the common 57-kb deletion in CTNS causing cystinosis. Hum Genet 115, 510–514 (2004). https://doi.org/10.1007/s00439-004-1170-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-004-1170-2